{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:41:35Z","timestamp":1768322495299,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite progress in the development of combined antiretroviral therapies (cART), HIV infection remains a significant challenge for human health. Current problems of cART include multi-drug-resistant virus variants, long-term toxicity and enormous treatment costs. Therefore, the identification of novel effective drugs is urgently needed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We developed a straightforward screening approach for simultaneously evaluating the sensitivity of multiple HIV gag-pol mutants to antiviral drugs in one assay. Our technique is based on multi-colour lentiviral self-inactivating (SIN) LeGO vector technology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We demonstrated the successful use of this approach for screening compounds against up to four HIV gag-pol variants (wild-type and three mutants) simultaneously. Importantly, the technique was adapted to Biosafety Level 1 conditions by utilising ecotropic pseudotypes. This allowed upscaling to a large-scale screening protocol exploited by pharmaceutical companies in a successful proof-of-concept experiment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The technology developed here facilitates fast screening for anti-HIV activity of individual agents from large compound libraries. Although drugs targeting gag-pol variants were used here, our approach permits screening compounds that target several different, key cellular and viral functions of the HIV life-cycle. The modular principle of the method also allows the easy exchange of various mutations in HIV sequences. In conclusion, the methodology presented here provides a valuable new approach for the identification of novel anti-HIV drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-6405-10-1","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T11:14:16Z","timestamp":1357211656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses"],"prefix":"10.1186","volume":"10","author":[{"given":"Maria M","family":"Prokofjeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Riecken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel V","family":"Spirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitriy V","family":"Yanvar\u00e9v","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"D\u00fcsedau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Ellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Fehse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Stocking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir S","family":"Prassolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"260_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.coph.2010.04.011","volume":"10","author":"E De Clerq","year":"2010","unstructured":"De Clerq E: Antiretroviral Drugs. Curr Opin Pharmacol. 2010, 10: 507-515. 10.1016\/j.coph.2010.04.011","journal-title":"Curr Opin Pharmacol"},{"key":"260_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jac\/dkq096","volume":"65","author":"B Taiwo","year":"2010","unstructured":"Taiwo B, Hicks C, Eron J: Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1. J Antimicrob Chemother. 2010, 65: 1100-1107. 10.1093\/jac\/dkq096","journal-title":"J Antimicrob Chemother"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ: The challenge of finding a cure for HIV infection. Science. 2009, 323: 1304-1307. 10.1126\/science.1165706","journal-title":"Science"},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.7326\/0003-4819-154-11-201106070-00345","volume":"154","author":"CW Dieffenbach","year":"2011","unstructured":"Dieffenbach CW, Fauci AS: Thirty Years of HIV and AIDS: Future challenges and opportunities. Ann Intern Med. 2011, 154: 766-771.","journal-title":"Ann Intern Med"},{"key":"260_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jmv.1040","volume":"64","author":"G J\u00e1rmy","year":"2001","unstructured":"J\u00e1rmy G, Heinkelein M, Weissbrich B, Jassoy C, Rethwilm A: Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system. J Med Virol. 2001, 64: 223-331. 10.1002\/jmv.1040","journal-title":"J Med Virol"},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1386-6532(99)00010-4","volume":"13","author":"H Walter","year":"1999","unstructured":"Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, Uberla K: Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol. 1999, 13: 71-80. 10.1016\/S1386-6532(99)00010-4","journal-title":"J Clin Virol"},{"key":"260_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/mt.2008.6","volume":"16","author":"K Weber","year":"2008","unstructured":"Weber K, Bartsch U, Stocking C, Fehse B: A multi-color panel of novel lentiviral \"gene ontology\" (LeGO) vectors for functional gene analysis. Mol Ther. 2008, 16: 698-706. 10.1038\/mt.2008.6","journal-title":"Mol Ther"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.exphem.2006.02.005","volume":"34","author":"A Schambach","year":"2006","unstructured":"Schambach A, Galla M, Modlich U: Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol. 2006, 34: 588-592. 10.1016\/j.exphem.2006.02.005","journal-title":"Exp Hematol"},{"key":"260_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1054\/drup.1999.0076","volume":"2","author":"D Arion","year":"1999","unstructured":"Arion D, Parniak MA: HIV resistance to zidovudine: the role of pyrophosphorolysis. Drug Resist Updat. 1999, 2: 91-95. 10.1054\/drup.1999.0076","journal-title":"Drug Resist Updat"},{"key":"260_CR10","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M: A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998, 72: 8463-8471.","journal-title":"J Virol"},{"key":"260_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999, 4: 67-73. 10.1177\/108705719900400206","journal-title":"J Biomol Screen"},{"key":"260_CR12","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gnh110","volume":"32","author":"L Zheng","year":"2004","unstructured":"Zheng L, Baumann U, Reymond JL: An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 2004, 32: e115- 10.1093\/nar\/gnh110","journal-title":"Nucleic Acids Res"},{"key":"260_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1134\/S0026893310050146","volume":"44","author":"PV Spirin","year":"2010","unstructured":"Spirin PV, Baskaran F, Orlova NN: [Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference]. Mol Biol (Mosk). 2010, 44: 876-888.","journal-title":"Mol Biol (Mosk)"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-6405-10-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:46:27Z","timestamp":1630532787000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/1742-6405-10-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/1742-6405-10-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]},"assertion":[{"value":"17 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}